Alexandra N. Mills

Alexandra N. Mills

Auto-generated profile, based on publicly available information

Alexandra N. Mills

Sean M. Healey & AMG Center for ALS at Mass General, Massachusetts General Hospital, Boston, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
TPTiziana Petrozziello
Tiziana Petrozziello
EBEvan A. Bordt
Evan A. Bordt
AMAlexandra N. Mills
Alexandra N. Mills
SKSpencer E. Kim
Spencer E. Kim
ESEllen Sapp
Ellen Sapp
GSGhazaleh Sadri-Vakili
Ghazaleh Sadri-Vakili

1 October 2020 in Neurobiology of Disease
Verified
Journal Article
Open access
TPTiziana Petrozziello
Tiziana Petrozziello
AMAlexandra N. Mills
Alexandra N. Mills
CVChristine A. Vaine
Christine A. Vaine
EPEllen B. Penney
Ellen B. Penney
CFCara Fernandez-Cerado
Cara Fernandez-Cerado
GSGhazaleh Sadri-Vakili
Ghazaleh Sadri-Vakili
Neuroinflammation plays a pathogenic role in neurodegenerative diseases and recent findings suggest that it may also be involved in X-linked Dystonia-Parkinsonism (XDP) pathogenesis. Previously, fibroblasts and neuronal stem cells derived from XDP patients demonstrated hypersensitivity to TNF-α, dysregulation in NFκB signaling, and an increase in several pro-inflammatory markers. However, the role of inflammatory processes in XDP patient brain remains unknown. Here we demonstrate that there is a significant increase in astrogliosis and microgliosis in human post-mortem XDP prefrontal cortex (PFC) compared to control. Furthermore, there is a significant increase in histone H3 citrullination (H3R2R8R17cit3) with a concomitant increase in peptidylarginine deaminase 2 (PAD2) and 4 (PAD4), the enzymes catalyzing citrullination, in XDP post-mortem PFC. While there is a significant increase in myeloperoxidase (MPO) levels in XDP PFC, neutrophil elastase (NE) levels are not altered, suggesting that MPO may be released by activated microglia or reactive astrocytes in the brain. Similarly, there was an increase in H3R2R8R17cit3, PAD2 and PAD4 levels in XDP-derived fibroblasts. Importantly, treatment of fibroblasts with Cl-amidine, a pan inhibitor of PAD enzymes, reduced histone H3 citrullination and pro-inflammatory chemokine expression, without affecting cell survival. Taken together, our results demonstrate that inflammation is increased in XDP post-mortem brain and fibroblasts and unveil a new epigenetic potential therapeutic target.

27 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EGEric J. Granucci
Eric J. Granucci
AGAna Griciuc
Ana Griciuc
KMKaly A. Mueller
Kaly A. Mueller
AMAlexandra N. Mills
Alexandra N. Mills
HLHoang Le
Hoang Le
GSGhazaleh Sadri-Vakili
Ghazaleh Sadri-Vakili
Accumulating evidence suggests that neuroinflammatory processes are implicated in the initiation and progression of amyotrophic lateral sclerosis (ALS). Previous reports have demonstrated an increase in microgliosis and astrogliosis in the lumbar spinal cord of SOD1G93Atransgenic mice before the onset of symptoms, a neuroinflammatory response which correlated with disease progression. Importantly, early stage homeostatic microglia enhanced motor neuron survival, while pro-inflammatory microglia were toxic to motor neurons in the SOD1G93Amice. Recent studies from our group have demonstrated that cromolyn sodium, an FDA approved compound, exerts neuroprotective effects in mouse models of Alzheimer’s disease by altering microglial cell activation. Here, we tested the neuroprotective and anti-inflammatory effects of cromolyn sodium in the SOD1G93Amouse model of ALS. Our results indicate that cromolyn sodium treatment significantly delayed the onset of neurological symptoms, and improved deficits in PaGE performance in both male and female mice, however, there was only an effect on survival in female mice. Furthermore, there was a significant increase in motor neuron survival in the lumbar spinal cord as well as a significant decrease in the denervation of the neuromuscular junction of the tibialis anterior muscle in cromolyn treated transgenic SOD1G93Amice. Lastly, cromolyn treatment decreased the expression of pro-inflammatory cytokines/chemokines in the lumbar spinal cord and plasma and decreased mast cell degranulation in the tibialis anterior muscle of transgenic SOD1G93Amice. Together, these findings suggest that cromolyn sodium provides neuroprotection in the SOD1G93Amice by decreasing the inflammatory response.

12 April 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
AMAlexandra Mills
Alexandra Mills
EBElizabeth Bearce
Elizabeth Bearce
RCRachael Cella
Rachael Cella
SKSeung Woo Kim
Seung Woo Kim
MSMegan Selig
Megan Selig
LLLaura Anne Lowery
Laura Anne Lowery
Wolf-Hirschhorn Syndrome (WHS) is a human developmental disorder arising from a hemizygous perturbation, typically a microdeletion, on the short arm of chromosome four. In addition to pronounced intellectual disability, seizures, and delayed growth, WHS presents with a characteristic facial dysmorphism and varying prevalence of microcephaly, micrognathia, cartilage malformation in the ear and nose, and facial asymmetries. These affected craniofacial tissues all derive from a shared embryonic precursor, the cranial neural crest (CNC), inviting the hypothesis that one or more WHS-affected genes may be critical regulators of neural crest development or migration. To explore this, we characterized expression of multiple genes within or immediately proximal to defined WHS critical regions, across the span of craniofacial development in the vertebrate model systemXenopus laevis. This subset of genes,whsc1,whsc2,letm1, andtacc3, are diverse in their currently-elucidated cellular functions; yet we find that their expression demonstrates shared tissue-specific enrichment within the anterior neural tube, migratory neural crest, and later craniofacial structures. We examine the ramifications of this by characterizing craniofacial development and neural crest migration following individual gene depletion. We observe that several WHS-associated genes significantly impact facial patterning, cartilage formation, neural crest motilityin vivoandin vitro, and can separately contribute to forebrain scaling. Thus, we have determined that numerous genes within and surrounding the defined WHS critical regions potently impact craniofacial patterning, suggesting their role in WHS presentation may stem from essential functions during neural crest-derived tissue formation.

5 May 2020 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
TPTiziana Petrozziello
Tiziana Petrozziello
AMAlexandra N. Mills
Alexandra N. Mills
SFSali M.K. Farhan
Sali M.K. Farhan
KMKaly A. Mueller
Kaly A. Mueller
EGEric J. Granucci
Eric J. Granucci
GSGhazaleh Sadri‐Vakili
Ghazaleh Sadri‐Vakili

15 October 2016 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
ERErin L. Rutherford
Erin L. Rutherford
LCLeslie Carandang
Leslie Carandang
PEPatrick T. Ebbert
Patrick T. Ebbert
AMAlexandra N. Mills
Alexandra N. Mills
JBJackson T. Bowers
Jackson T. Bowers
LLLaura Anne Lowery
Laura Anne Lowery
Microtubule dynamics is regulated by plus end–tracking proteins (+TIPs), which localize to the plus ends of microtubules (MTs). We previously showed that TACC1 and TACC3, members of the transforming acidic coiled-coil protein family, can act as +TIPs to regulate MT dynamics in Xenopus laevis. Here we characterize TACC2 as a +TIP that localizes to MT plus ends in front of EB1 and overlapping with TACC1 and TACC3 in multiple embryonic cell types. We also show that TACC2 can promote MT polymerization in mesenchymal cells but not neuronal growth cones, thus displaying cell-type specificity. Structure–function analysis demonstrates that the C-terminal region of TACC2 is both necessary and sufficient to localize to MT plus ends and promote increased rates of MT polymerization, whereas the N-terminal region cannot bind to MT plus ends but can act in a dominant-negative capacity to reduce polymerization rates. Finally, we analyze mRNA expression patterns in Xenopus embryos for each TACC protein and observe neural enrichment of TACC3 expression compared with TACC1 and TACC2, which are also expressed in mesodermal tissues, including somites. Overall these data provide a novel assessment of all three TACC proteins as a family of +TIPs by highlighting the unique attributes of each, as well as their collective characteristics.